A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.

Completed · Phase 3

Conditions studied: Hypertension

In brief

To compare the aliskiren regimen versus the ramipril regimen on reduction in Blood Pressure.

Key facts

Study ID

NCT00219063

Run by

Novartis

People needed

844

Starts

2005-02-01

Expected to finish

2006-03-01

Last updated by the study team

2017-05-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with essential hypertension
• Patients who are eligible and able to participate in the study

You may not qualify if…

• Severe hypertension
• History or evidence of a secondary form of hypertension
• History of Hypertensive encephalopathy or cerebrovascular accident. Other protocol-defined inclusion exclusion criteria also apply.

Where it is running

• Novartis Pharmaceuticals — East Hanover, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.